Other

Novartis Q4 net profit rebounds to $2.1 billion

(AP)—Swiss drug maker Novartis AG reported a jump in fourth-quarter net profit to $2.08 billion on Wednesday, citing the lack of a $900-million one-time charge it took in the same period the previous year.

Medications

Indian court to rule on generic drug industry

(AP)—From Africa's crowded AIDS clinics to the malarial jungles of Southeast Asia, the lives of millions of ill people in the developing world are hanging in the balance ahead of a legal ruling that will determine whether ...

Medications

Signifor approved for Cushing's disease

(HealthDay)—Signifor (pasireotide diaspartate) has been approved by the U.S. Food and Drug Administration to treat Cushing's disease in cases that cannot be treated by surgery.

Medications

Just-approved flu vaccine uses newer production method

(HealthDay)—Flucelvax is the first seasonal flu vaccine to be approved by the U.S. Food and Drug Administration using a manufacturing method called cell culture technology, the agency said.

Medications

Italy lifts ban on Novartis flu vaccines

Italian health authorities on Friday lifted a ban on the sale of flu vaccines made by Swiss pharmaceutical giant Novartis, saying that tests had shown they were not a health risk.

Diseases, Conditions, Syndromes

Once-yearly zoledronic acid benefits men with osteoporosis

(HealthDay)—For men with osteoporosis, a once-yearly infusion with zoledronic acid is associated with fewer vertebral fractures and improved bone health compared with placebo, according to a study published in the Nov. ...

Medications

Switzerland, Canada lift ban on Novartis flu vaccine

Swiss and Canadian health authorities on Wednesday lifted a ban on sales of flu vaccines made by Swiss pharmaceutical giant Novartis after determining they were safe and efficient.

Medications

Germany orders recall of some Novartis flu shots

(AP)—German authorities ordered a recall Thursday of some batches of Novartis flu vaccine as a precautionary measure after the company reported the appearance of small particles in the manufacturing process.

page 10 from 16